| Literature DB >> 29744292 |
Jesper Torbøl Pedersen1,2, Tamara Kanashova3, Gunnar Dittmar3,4, Michael Palmgren1.
Abstract
The yeast plasma membrane H+-ATPase Pma1p is a P-type ATPase that energizes the yeast plasma membrane. Pma1p exists in two activation states: an autoinhibited basal state and an activated state. Here we show that functional and stable Pma1p can be purified in native form and reconstituted in artificial liposomes without altering its activation state. Acetylated tubulin has previously been reported to maintain Pma1p in the basal state but, as this protein was absent from the purified preparations, it cannot be an essential component of the autoinhibitory mechanism. Purification of and reconstitution of native Pma1p in both activation states opens up for a direct comparison of the transport properties of these states, which allowed us to confirm that the basal state has a low coupling ratio between ATP hydrolysis and protons pumped, whereas the activated state has a high coupling ratio. The ability to prepare native Pma1p in both activation states will facilitate further structural and biochemical studies examining the mechanism by which plasma membrane H+-ATPases are autoinhibited.Entities:
Keywords: Pma1p; P‐type ATPase; acetylated tubulin; autoinhibitory regulation
Year: 2018 PMID: 29744292 PMCID: PMC5929935 DOI: 10.1002/2211-5463.12413
Source DB: PubMed Journal: FEBS Open Bio ISSN: 2211-5463 Impact factor: 2.693
Kinetic parameters of Pma1p in the basal and activated state and the effect of detergent treatment. The apparent activity was determined as specific activity (μmol Pi/mg protein/min) (n = 3 biological replicates; ± SE). n.a., not analyzed
| Protein state | Detergent | Protein:Detergent ratio | mg protein·L−1 media |
|
|
|---|---|---|---|---|---|
| Basal state | |||||
| Plasma membrane | – | – | 1.2 | 2.4 ± 0.7 | 4.0 ± 0.5 |
| Solubilized | OG | 1 : 3 | 0.9 | 2.3 ± 0.6 | 1.9 ± 0.2 |
| Solubilized | cymal‐7 | 1 : 4 | 0.8 | 2.5 ± 0.4 | 3.5 ± 0.1 |
| Solubilized | C12E8 | 1 : 4 | 0.5 | n.a. | n.a. |
| Solubilized | LDAO | 1 : 4 | 1.0 | 2.1 ± 0.7 | 0.9 ± 0.3 |
| Reactive Red 120 | cymal‐7 | 1 : 3 | 0.6 | 2.3 ± 0.3 | 4.1 ± 0.2 |
| Activated state | |||||
| Plasma membrane | – | – | 1.2 | 0.6 ± 0.1 | 11.7 ± 0.3 |
| Solubilized | OG | 1 : 3 | 0.9 | 0.6 ± 0.1 | 5.5 ± 0.2 |
| Reactive Red 120 | cymal‐7 | 1 : 3 | 1.0 | 0.4 ± 0.2 | 12.5 ± 0.9 |
Figure 1Purity of Pma1p in the basal state. The purity of Pma1p at different purification steps analyzed using (A) SDS/PAGE; 10% and (B) immunoblot with specific Pma1p antibodies. Ten micrograms of protein was used for the SDS/PAGE and 3 μg for the immunoblot. (C) Immunoblot of acetylated tubulin. Lane 1, crude plasma membrane fraction; lane 2, crude PM stripped with a KCl wash; lane 3, cymal‐7‐solubilized Pma1p; lane 4, nonsolubilized material; lane 5, Reactive Red 120‐purified Pma1p. LC‐MS/MS‐identified contaminating proteins are marked in lane 5.
Proteins present in the Pma1p preparation. Proteins were identified by LC‐MS/MS. Polypeptides with an intensity of above 2.5 × 109 are shown. For the full list, see Table S1
| Protein ID | Description | Intensity × 109 | |
|---|---|---|---|
| YGL008C | Pma1p | 99.6 kDa | 778 |
| YOR270C | Vph1p (vacuolar ATPase, VO domain) | 95.5 kDa | 2.5 |
| YHR042W | Ncp1p (NADP‐cytochrome reductase) | 76.7 kDa | 2.9 |
| YMR008C | Plb1p (phospholipase B) | 71.6 kDa | 20 |
| YMR307W | Gas1p (cell wall protein) | 59.5 kDa | 6.7 |
| YKL103C | Ape1p (vacuolar aminopeptidase) | 57.0 kDa | 4.2 |
| YOL030W | Gas5p (cell wall protein) | 51.8 kDa | 13 |
| YBR078W | Ecm33p (cell wall protein) | 48.2 kDa | 5.8 |
| YJL171C | Toh1p (cell wall protein) | 42.9 kDa | 18 |
| YGR282C | Bgl2p (cell wall protein) | 34.1 kDa | 2.6 |
| YNL055C | Por1p (mitochondrial porin) | 30.3 kDa | 37 |
Figure 2Proton/ATP coupling ratio is not affected by purification. Purified Pma1p in both activation states was reconstituted into lecithin vesicles and the (H+ transport/ATP hydrolysis) coupling ratio was analyzed. (A) ATP hydrolysis by Pma1p (2.5 μg) in the activated state (●) is about four times higher than that in the basal state (▲). As a comparison, ATP hydrolysis mediated by four times the amount of protein (10 μg) in the basal state is shown (■). Hydrolysis of ATP was coupled to the reduction in NADH measured as fluorescence quenching at 340 nm. (B) Initial rates of H+ pumping by Pma1p (2.5 μg) in the activated state (●) are much higher than in the basal state (▲). As a comparison, H+ pumping by four times the amount of protein (10 μg) in the basal state is shown (■). H+ transport was detected by monitoring the quenching of ACMA fluorescence. The assay was started after 150 s by adding 8 mm MgSO4 (final concentration), and the pH gradient generated was collapsed after 750 s by adding nigericin. Fluorescence before MgSO4 addition was set to 100% and the difference in coupling ratio was estimated using linear regression in the linear area of the ACMA fluorescence curve. (C) The H+ transport/ATP hydrolysis coupling ratio is approximately five times higher in the activated state than in the basal state, that is, H+ pumping efficiency per ATP split increases fivefold when the pump is post‐translationally activated. The maximal number of H+ per ATP hydrolyzed in the activated state is one 11. With a given value of one H+ per hydrolyzed ATP for Pma1p in the activated state, the number of H+ per hydrolyzed ATP in the basal state is calculated based on the difference between the linear regressions of fluorescence. (D) Immunoblot of purified Pma1p (2.5 μg) in the activated (lane 1) and basal (lane 2) state as a control for equal amount of Pma1p protein in the assay. (E) Coomassie Blue stained SDS/PAGE gel (10%)‐purified Pma1p (2.5 μg) in the activated (lane 1) and basal (lane 2) state as a control for the same purity of the two preparations.
Figure 3Long‐term stability of purified Pma1p. Purified Pma1p in the basal state was incubated with either (A) no inhibitor, (B) 1 mm AlFx, or (C) 1 mm ADP‐AlFx for up to 3 weeks. Samples of 1 μg protein were precipitated with trichloroacetic acid at the given time points, and their polypeptide composition was analyzed by immunoblotting using anti‐Pma1p antibody.